Why Lipocine Inc. (LPCN) Stock plunged in premarket?
Clarus Therapeutics Defeats Lipocine’s (NASDAQ: LPCN) Patent Infringement Lawsuit On Summary JudgmentasFederal Circuit Judge William C. Bryson, granted Clarus’s motion for summary judgment against Lipocine, Inc. for failure to provide an appropriate written description of Lipocine’s asserted patent declarations. LPCN stock price plummeted adjacent to the news. Lipocine Inc. (LPCN) shares were falling -15.33% to […]
